In the first installment of Gry Dahle’s Guest Editor Series, Gilbert Tang describes the evolution of transcatheter aortic valve replacement. He goes over the method’s history, limitations, and future directions.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Transcatheter
March 27, 2023
In the newest entry into the CTSNet Guest Editor Series collection, “20 Years After First TAVI: Will the Pace of Innovations Continue for All Heart Valves?” Gry Dahle, MD, PhD presents a curated collection of videos on the history, current challenges, and future advances of transcatheter valve replacement.
March 27, 2023
Gry Dahle shares insights on her prolific work in valve surgery, the emergence of artificial intelligence in medicine, and the importance of building in interdisciplinary surgical team.
March 9, 2023
A variety of procedures make up CTSNet’s catalog of heart valve content, which has continued to expand as surgeons increasingly focus on perfecting valve surgeries. Explore five of the most popular heart valve videos on the site in the past year and let us know your favorite in the comments.
February 23, 2023
A new study found that patients who undergo TAVR with concomitant chronic total occlusion lesions are more likely to experience complications from the procedure, but they do not have a higher risk of mortality. The results suggest that if a patient is otherwise a candidate for TAVR, their CTO status should not exclude them from the surgery.
February 9, 2023
Since the recent increase of TAVR to treat aortic valve disease, multidisciplinary heart teams consisting of surgeons, cardiologists, and other allied professionals have become a necessary component in a successful surgery.
February 9, 2023
The rate of serious complications in transcatheter aortic valve implantation (TAVI) has decreased markedly in recent years, going from 5.5 percent in 2012 to 2 percent in 2019. However, the total number of adverse events remains around 500, with about 100 requiring conversion to sternotomy, because of increased use of the procedure.
January 27, 2023
A novel self-expanding TAVR valve has been successfully implanted in ten patients, as reported by a research team in China. The new device is made of a self-expanding nitinol stent with three valve leaflets of bovine pericardial, reduces the risk of coronary obstruction, and is completely retrievable and repositionable.
January 20, 2023
A team at the University of California Davis was the first on the west coast to perform a mitral valve replacement with new minimally invasive valve technology.
January 12, 2023
INTEGRITTY, a group dedicated the appraisal of evidence to support optimized patient management, published a paper highlighting concerns surrounding major TAVR versus SAVR studies. While their findings do not aim to directly discredit the studies, they do raise questions about the integrity of their methodology.